Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Autoimmunity Reviews|January 27, 2022
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry"Brenda López-Benjume, Ignasi Rodríguez-Pintó, Mary Carmen Amigo, et al.
Arthritis Care & Research|July 18, 2013
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literatureLaura Andreoli, Cecilia B Chighizola, Alessandra Banzato, et al.
Autoimmunity Reviews|June 20, 2013
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximabHoracio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
The Journal of Rheumatology|July 3, 2023
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee ReportMedha Barbhaiya, Maxime Taghavi, Stephane Zuily, et al.
Arthritis and Rheumatism|July 27, 2006
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patientsSilvia Bucciarelli, Gerard Espinosa, Ricard Cervera, et al.
Autoimmunity Reviews|August 9, 2021
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysisInès Bernardoff, Alexandre Picq, Pierre Loiseau, et al.
Arthritis Care & Research|November 30, 2020
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate CriteriaMedha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, et al.
Autoimmunity Reviews|July 30, 2022
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysisVinicius Domingues, Eugenia Yupei Chock, Virginie Dufrost, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 2, 2021
Defibrotide Inhibits Antiphospholipid Antibody-Mediated Neutrophil Extracellular Trap Formation and Venous ThrombosisRamadan A Ali, Shanea K Estes, Alex A Gandhi, et al.
Pageof 18